identification of the gemcitabine resistant signature for predicting prognosis in patients
Published 3 years ago • 30 plays • Length 2:48Download video MP4
Download video MP3
Similar videos
-
2:27
identification of pathway signatures associated with prognosis in pancreatic cancer
-
2:31
the role of ferroptosis regulators in the prognosis, immune activity and gemcitabine resistance
-
8:22
pancreatic cancer properties describe gemcitabine response
-
3:35
identification of pancreatic transcriptome signature during chronic pancreatitis recovery in
-
14:29
03 identification of gene signatures associated with gemcitabine response in pdac patients using knn
-
3:19
a dna methylation signature to improve survival prediction of pancreatic cancer
-
3:45
detection of chemotherapy-resistant pancreatic cancer using a glycan biomarker
-
2:52
m6aregulators-based signature identified distinct immune infiltration pattern survival in pancreatic
-
1:57
the protein rrp9 promotes gemcitabine resistance in pancreatic cancer by activating the akt pathway
-
1:54
chemical signature of pancreatic cancer allows doctors to identify cancer cells & predict outcomes
-
2:55
development and validation of a cimp-associated prognostic model for pancreatic cancer
-
2:42
prognostic value of circulating tumor dna in pancreatic cancer a systematic review and meta-analysis
-
0:58
dr. weinberg discusses the use of folfirinox in older patients with metastatic pancreatic cancer
-
2:56
patient-derived organoids as a model for predicting drug response in pancreas malignancies
-
1:19:34
novel and emerging therapeutics in pdac
-
7:07
pancreatic cancer: chemoresistance & gemcitabine intracellular reprogramming in tumor #code: 591
-
11:08
epithelial to mesenchymal transition and stemness in pancreatic cancer, mouad edderkaoui, phd
-
2:42
evaluation of preoperative prognostic factors in patients with resectable invasive intraductal
-
5:35
01 identification of gemcitabine responder vs non responder in pdc patients